Esperion Therapeutics, INC.
At a glance
Employees100-499
In business sinceNot reported
HeadquartersAnn Arbor, MI
US patents60
SAM.gov UEINS7JNKSMBL25
CAGE code62GZ9
Incorporated inDE
LEI549300OFU56UKEWVUS92
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
60 US patents granted 1999–2025, 11 of them in the five years to SEP 2025.
Pharmaceuticals 40Organic fine chemistry 15Biotechnology 3Measurement 2
- Methods of making bempedoic acid and compositions of the sameUS 12,404,227 · granted SEP 2, 2025
- Methods of making bempedoic acid and compositions of the sameUS 12,398,087 · granted AUG 26, 2025
- Salt forms of bempedoic acid and methods for using the sameUS 12,344,578 · granted JUL 1, 2025
- Methods of making bempedoic acid and compositions of the sameUS 11,987,548 · granted MAY 21, 2024
- Methods of making bempedoic acid and compositions of the sameUS 11,926,584 · granted MAR 12, 2024
Newest 5 shown · Granted to Esperion Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Esperion Therapeutics, INC. | Ann Arbor | MI | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.